IL17A and psoriasis: In another study with psoriasis patients, IL-17 gene expression levels in the skin were decreased after 14 days of treatment with etanercept [39], but this study reported a much higher median body surface area (BSA) score for psoriasis, and thus, consisted of patients with more severe psoriasis.